Thanks for sharing great investment thesis on RVNC.
I did not get into Enanta exactly for the reasons you mentioned. So feel like getting a second chance.
With odds of successful P3 trial now high, market potential for RT002 injectable is high. I agree with you buyout is likely too in future if all goes well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.